Support for CIN 2-3 being an immediate result of infection by high-risk types of HPV comes from the observation in one study (8) that incident CIN 2-3 occurred shortly after detection of HPV 16 or 18 DNA among women who were cytologically negative at study entry. Furthermore, infection of human keratinocyte rafts with HPV 16 results in a morphologic lesion resembling CIN 2-3 (9), but infection by HPV 6 is more likely to result in a lesion resembling CIN 1. Whether the 20%-30% of CIN 1 lesions containing HPV 16 could progress to carcinoma, or whether the type of epithelium (mature, versus immature squamous epithelium) is important in determining the natural history of infection with specific HPV types, requires further investigation. We must also reassess whether such findings are simply the result of small areas of CIN 2-3 missed on routine cytologic sampling because of size or location (e.g., within glands) or perhaps a slower rate of exfoliation of cells.
Much of cancer research is aimed at identifying the differences between normal and malignant cells so that a therapeutic window can be established, using an agent that will kill enough tumor cells to control the disease without causing excessive normal tissue damage. It has been recognized, however, that cells of both tumors and normal tissues can be killed by two mechanisms: 1) direct damage to the cells or 2) indirect damage to the cells resulting from injury to the vascular network. This vasculature-mediated injury has for many years been of particular interest to radiobiologists and radiotherapists, since it may be partly or totally responsible for late normal-tissue damage occurring many months after the treatment has been completed (/) . Thus, an understanding of the factors controlling vascular radiosensitivity could allow us to reduce late complications of therapy.
The reason why late changes are seen after radiation therapy relates to the fact that DNA damage, although inflicted within microseconds by ionizing radiation, can remain latent in cells for months, not interfering with the normal biochemistry of the cells, but becoming evident only when the cells attempt to divide (2) . Abortive mitoses lead to cellular depletion and to proliferative sterilization of the progenitors that should repopulate the damaged tissue or tumor. Vascular endothelial cells in all normal tissues have a very slow rate of proliferation, with a turnover time of months to years (5); hence, there should be a long latency before the abortive divisions take place and tissue dysfunction is recognized. Of course, if the parenchymal cells in the tissue are also slow growing, the direct radiation injury to *See "Notes" section following "References." those cells will also show a long latency, and careful, detailed studies are required to distinguish direct cell kill from injury mediated through damage to the vasculature (4).
In 1982, it was recognized that endothelial cell proliferation in tumors is very much faster than in normal tissues (5),. and these cells were identified as a potential new target for therapy (6, 7) . Since that time, vasculature-mediated damage to tumors has been identified as an important constituent in the tumor response to various forms of therapy, such as hyperthermia, photodynamic therapy, cytokines, and some drugs . In the last 5 years, an increasing amount of attention has been focused on this possible new target, as exemplified by the Gray Conference Proceedings published in 1991 (14) . Although these physical and chemical agents have been shown to cause cessation of blood flow leading to hemorrhagic or ischemic necrosis, there has been no evidence for such an effect with ionizing radiation.
The recognition of the hallmarks of vasculature-mediated injury depends on the time scale and pattern of injury that can be seen shortly after the vessels have been damaged (thrombosed, occluded by pressure, or ruptured). For example, characteristic of vasculature-mediated injury is the presence of patchy, large areas of necrosis, with individual cords of cells surrounding the few vessels that are still functional. Because of the variable latent period before damage is expressed after radiation therapy, the absence of this histology in tumors assessed shortly after irradiation could not prove or disprove the relative contributions of direct versus vasculature-mediated injury. Experiments in the 1960s had indicated that stromal damage might be expressed in tumors only when the tumor mass was regrowing after ineffective therapy (75). That study implied, although it did not state, that the endothelial cells were not proliferating during the regression phase and that the latent DNA damage in them had not been expressed until regrowth occurred. The injury to the cells, therefore, would not contribute much to the extensive cell kill needed to cause local control, i.e., prevent local regrowth. It was, however, possible to show that preirradiating the epidermis and dermis of mice before implantation of tumor cells could slow down the tumor growth rate by damaging vasculature, even though the tumor cells themselves had received no treatment (16) . This effect became known as the "tumor bed effect."
The difficulty of resolving whether tumor vasculature has any influence on local tumor control after radiotherapy has been nicely addressed by a study reported in this issue of the Journal by Budach et al. (77). Budach et al. have ingeniously used as hosts for a series of different murine and human tumors an inbred mutant mouse strain whose normal tissue is approximately three times more sensitive to radiation than that of other mouse strains. Their experimental design ensured that the stromal component of the tumor derived from the host, not from the original donor animals. They have compared the growth characteristics of the tumors in normal and radiosensitive hosts, both in untreated mice and in mice with tumors regrowing after irradiation with x rays. By giving appropriate ranges of single doses, they have also established the x-ray dose needed to completely and permanently eradicate irradiated tumors in 50% of the animals (tumor control dose, TCD 50 ). If direct damage to tumor cells is the only factor determining the level of cell depletion, we would expect the TCDJQ to be similar in the radiosensitive and normal mice. If, however, vasculaturemediated injury is important after radiation therapy, we would expect the TCD^ to be lower in the mice that have a threefold greater intrinsic stromal radiosensitivity. Indeed the extent to which the TCD^ is reduced in a radiosensitive host could in theory be used to calculate what fraction of the damage is direct versus indirect.
Budach et al. (77) have convincingly shown that the intrinsic radiosensitivity of the host stroma has no influence on die TCD 50 . They have used large, single x-ray doses and made the tumors uniformly radioresistant during irradiation by using clamps to block the blood flow to the tumorbearing leg. These features are both irrelevant for clinical applications, but this experimental design removes any doubts about diferences in hypoxic fraction or in the repair characteristics in the different hosts. As an important control, earlier work by Budach et al. (18) has shown that, if tumors are induced by carcinogens to originate from the normal tissues of these radiosensitive mice, they have an increase in radiosensitivity similar to that seen in the normal tissues.
The conclusions drawn from the present study, i.e., that vascular damage is not a significant factor in tumor response to radiotherapy, are not in conflict with conclusions drawn from other studies (7, 75, 79) . They show that radiation therapy is not in the same category of cytotoxic agents as hyperthermia, photodynamic therapy, cytokines, or some chemotherapeutic agents. Even if some damage is mediated through radiation injury to endothelial cells, the data obtained by Budach et al. (17) clearly demonstrate that such damage is a minor component after x rays.
It is curious that the data of Budach et al. (17) also shed doubt on whether the altered regrowth rate of irradiated tumors is a measure of latent injury being expressed in the vasculature as new angiogenic demands are made (15) . The extent of the treatment-induced slowing of tumor growth is similar in the different host animals, indicating similar vascular effects at equal x-ray doses regardless of stromal radiosensitivity. It could, however, reflect a saturation of the tumor bed effect because the doses are so high, as described by Begg and Denekamp (20) . It is perhaps worth noting that, with the agents that have been shown to cause vascular damage in tumors, the effect seems to be abrupt and is not accompanied by a delayed or latent tumor bed effect. Indeed, tumors regrowing after vasculature-mediated injury show growth curves parallel to those seen in untreated tumors or may even show accelerated growth (27).
The report by Budach et al. in this issue nicely illustrates the benefits that can be derived from lateral thinking and from the use of an ingenious model system. Budach et al. also indicate (by their appropriate exclusion of one subset of tumors) the care that must always be exercised in making sure that the tumor model is appropriate to the question being posed and that the data are not compromised by artifacts of immune rejection (22) (23) (24) .
